Please assess the completion status of the following clinical trial:

Trial Title: Peritoneal Dialysis in Congestive Heart Failure

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Age \> 18 years~* Refractory Left Ventricular Congestive Heart Failure: LVEF \< 30%~* Diminished renal function: eGFR \< 60 ml/min~* Clinically volume overloaded (Dyspnoea (NYHA III-IV), edema, and/or ascites)~* Hospitalization for CHF during the last 6 months~* Patient is on optimal cardiologic medical therapy, which has been stable for more than 4 weeks~* Suitable for PD~Exclusion Criteria:~* Hypotension (SBP \< 100 mmHg / MAP \< 70) mmHg~* Instable AP or recent (\< 6 months) myocardial infarction.~* Contraindications for PD (e.g. visual handicap, social)~* Liver failure~* COPD Gold class IV~* Malignancy with life expectancy \< 2 years~* Non compliance~* No informed consent~* Poor mental health

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Standard Care (Type: SHAM_COMPARATOR): None
- 2 Icodextrin PD changes / day (Type: ACTIVE_COMPARATOR): None
- 1 Icodextrin PD change/day (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).